Elevated Th17 Cells Are Accompanied by FoxP3+ Treg Cells Decrease in Patients with Lupus Nephritis

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2011 Jan 19

PMID 21243492

Citations 59

Authors

Qian Xing

Bin Wang

Houheng Su

Jiajia Cui

Jinghua Li

Affiliations

Soon will be listed here.

Abstract

To investigate the variations of T-helper 17 (Th17) and regulatory T (Treg) cells in patients with lupus nephritis (LN), a total of 60 systemic lupus erythematosus patients and 28 healthy controls (HCs) were enrolled. The frequency of Th17 cells and Treg cells in peripheral blood mononuclear cells (PBMCs) was evaluated by flow cytometric analysis. The serum concentrations of interleukin-17 (IL-17) and transforming growth factor-beta 1 (TGF-β1) were measured by enzyme-linked immunosorbent assay (ELISA). The results demonstrated in LN patients a significant decrease in the frequency of CD4+CD25(high) and CD4+CD25+FoxP3+ T cells and a significant increase in the frequency of Th17 cells in peripheral blood, and the ratio of Th17 to Treg cell frequency was significantly increased along with increased SLEDAI scores. LN patients had a lower percentage and expression of FoxP3 in CD4+CD25(high) T cells than SLE patients without nephritis. The concentration of TGF-β1 was found decreased in SLE patients compared with that from healthy controls, though no significant difference was found between LN patients and SLE patients without nephritis. The expression of IL-17 levels in LN patients exhibited a significant increase compared with patients without nephritis and healthy controls. Based on our results, the significantly elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in lupus nephritis, suggesting that Th17/Treg functional imbalance may be involved in the pathogenesis of renal damage in SLE patients.

Citing Articles

Immune imbalance in Lupus Nephritis: The intersection of T-Cell and ferroptosis.

Fan Y, Ma K, Lin Y, Ren J, Peng H, Yuan L Front Immunol. 2024; 15:1520570.

PMID: 39726588 PMC: 11669548. DOI: 10.3389/fimmu.2024.1520570.

Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis.

Huang J, Li X, Zhu Q, Wang M, Xie Z, Zhao T Front Immunol. 2024; 15():1425847.

PMID: 39086480 PMC: 11288813. DOI: 10.3389/fimmu.2024.1425847.

Global research trends in precision-targeted therapies for systemic lupus erythematosus (2003-2023): A bibliographic study.

Yuan Z, Zhang W, Jin Z, Wang Y, Lin Z, Xie Z Heliyon. 2024; 10(13):e33350.

PMID: 39050478 PMC: 11268211. DOI: 10.1016/j.heliyon.2024.e33350.

Efficacy, safety and the lymphocyte subsets changes of low-dose IL-2 in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Su Q, Luo J, Wang X, Di J, Cao Y, Zhang S Immun Inflamm Dis. 2024; 12(1):e1165.

PMID: 38270322 PMC: 10808945. DOI: 10.1002/iid3.1165.

Cytokines in Systemic Lupus Erythematosus-Focus on TNF-α and IL-17.

Richter P, Macovei L, Mihai I, Cardoneanu A, Burlui M, Rezus E Int J Mol Sci. 2023; 24(19).

PMID: 37833861 PMC: 10572174. DOI: 10.3390/ijms241914413.

References

Zhang B, Zhang X, Tang F, Zhu L, Liu Y . Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol. 2008; 153(2):182-7. PMC: 2492897. DOI: 10.1111/j.1365-2249.2008.03686.x. View

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

Kang H, Liu M, Datta S . Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol. 2007; 178(12):7849-58. DOI: 10.4049/jimmunol.178.12.7849. View

Langrish C, Chen Y, Blumenschein W, Mattson J, Basham B, Sedgwick J . IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201(2):233-40. PMC: 2212798. DOI: 10.1084/jem.20041257. View

Fontenot J, Gavin M, Rudensky A . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003; 4(4):330-6. DOI: 10.1038/ni904. View

Mok C, Ying K, Ng W, Lee K, To C, Lau C . Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med. 2006; 119(4):355.e25-33. DOI: 10.1016/j.amjmed.2005.08.045. View

Nalbandian A, Crispin J, Tsokos G . Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009; 157(2):209-15. PMC: 2730846. DOI: 10.1111/j.1365-2249.2009.03944.x. View

Zhang B, Zhang X, Tang F, Zhu L, Liu Y, Lipsky P . Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann Rheum Dis. 2008; 67(7):1037-40. DOI: 10.1136/ard.2007.083543. View

Gavin M, Rasmussen J, Fontenot J, Vasta V, Manganiello V, Beavo J . Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007; 445(7129):771-5. DOI: 10.1038/nature05543. View

10.

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

11.

Crispin J, Martinez A, Alcocer-Varela J . Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003; 21(3):273-6. DOI: 10.1016/s0896-8411(03)00121-5. View

12.

Nakae S, Nambu A, Sudo K, Iwakura Y . Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003; 171(11):6173-7. DOI: 10.4049/jimmunol.171.11.6173. View

13.

Baecher-Allan C, Brown J, Freeman G, Hafler D . CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001; 167(3):1245-53. DOI: 10.4049/jimmunol.167.3.1245. View

14.

Barath S, Aleksza M, Tarr T, Sipka S, Szegedi G, Kiss E . Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus. Lupus. 2007; 16(7):489-96. DOI: 10.1177/0961203307080226. View

15.

Vargas-Rojas M, Crispin J, Richaud-Patin Y, Alcocer-Varela J . Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus. 2008; 17(4):289-94. DOI: 10.1177/0961203307088307. View

16.

Crispin J, Oukka M, Bayliss G, Cohen R, Van Beek C, Stillman I . Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008; 181(12):8761-6. PMC: 2596652. DOI: 10.4049/jimmunol.181.12.8761. View

17.

Heinlen L, McClain M, Merrill J, Akbarali Y, Edgerton C, Harley J . Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. 2007; 56(7):2344-51. DOI: 10.1002/art.22665. View

18.

Mellor-Pita S, Citores M, Castejon R, Tutor-Ureta P, Yebra-Bango M, Andreu J . Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis. 2006; 65(4):553-4. PMC: 1798083. DOI: 10.1136/ard.2005.044974. View

19.

Dong G, Ye R, Shi W, Liu S, Wang T, Yang X . IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med J (Engl). 2003; 116(4):543-8. View

20.

Hsu H, Yang P, Wang J, Wu Q, Myers R, Chen J . Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2007; 9(2):166-75. DOI: 10.1038/ni1552. View